Cargando…

Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol

BACKGROUND: A previous study has shown similar factors in dyslipidemias (DL) and osteoporosis (OP). However, no cohort study has been reported on the association between DL and OP in the postmenopausal population in China. This study aims to provide epidemiological and pathophysiological evidence re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xu, Zhang, Yili, Sun, Chuanrui, Qi, Baoyu, Huang, Xinyi, Chen, Ming, Liu, Ning, Sun, Kai, Chen, Xin, Qin, Xiaokuan, Xie, Yanming, Zhu, Liguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515467/
https://www.ncbi.nlm.nih.gov/pubmed/36186975
http://dx.doi.org/10.3389/fcvm.2022.901786
_version_ 1784798487781572608
author Wei, Xu
Zhang, Yili
Sun, Chuanrui
Qi, Baoyu
Huang, Xinyi
Chen, Ming
Liu, Ning
Sun, Kai
Chen, Xin
Qin, Xiaokuan
Xie, Yanming
Zhu, Liguo
author_facet Wei, Xu
Zhang, Yili
Sun, Chuanrui
Qi, Baoyu
Huang, Xinyi
Chen, Ming
Liu, Ning
Sun, Kai
Chen, Xin
Qin, Xiaokuan
Xie, Yanming
Zhu, Liguo
author_sort Wei, Xu
collection PubMed
description BACKGROUND: A previous study has shown similar factors in dyslipidemias (DL) and osteoporosis (OP). However, no cohort study has been reported on the association between DL and OP in the postmenopausal population in China. This study aims to provide epidemiological and pathophysiological evidence regarding the association between DL and bone mass and fracture risk. METHODS: This is a multicenter, prospective cohort study that will have approximately 1,100 representative participants enrolled from multiple hospitals or communities in China. They will be divided into two groups according to whether or not they are exposed to dyslipidemia and will be epidemiologically investigated. Each participant will be visited continuously once every year with a minimum follow-up of 3 years to track incidences of OP. Meanwhile, free bone density screening, questionnaires, and blood sample collection will also be completed during this period. CONCLUSION: The current study is likely to provide greater insight into the relationship between lipid metabolism and bone metabolism in postmenopausal women. Furthermore, the research result maybe fed into public health strategies with regard to metabolic disease prevention.
format Online
Article
Text
id pubmed-9515467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95154672022-09-29 Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol Wei, Xu Zhang, Yili Sun, Chuanrui Qi, Baoyu Huang, Xinyi Chen, Ming Liu, Ning Sun, Kai Chen, Xin Qin, Xiaokuan Xie, Yanming Zhu, Liguo Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: A previous study has shown similar factors in dyslipidemias (DL) and osteoporosis (OP). However, no cohort study has been reported on the association between DL and OP in the postmenopausal population in China. This study aims to provide epidemiological and pathophysiological evidence regarding the association between DL and bone mass and fracture risk. METHODS: This is a multicenter, prospective cohort study that will have approximately 1,100 representative participants enrolled from multiple hospitals or communities in China. They will be divided into two groups according to whether or not they are exposed to dyslipidemia and will be epidemiologically investigated. Each participant will be visited continuously once every year with a minimum follow-up of 3 years to track incidences of OP. Meanwhile, free bone density screening, questionnaires, and blood sample collection will also be completed during this period. CONCLUSION: The current study is likely to provide greater insight into the relationship between lipid metabolism and bone metabolism in postmenopausal women. Furthermore, the research result maybe fed into public health strategies with regard to metabolic disease prevention. Frontiers Media S.A. 2022-09-14 /pmc/articles/PMC9515467/ /pubmed/36186975 http://dx.doi.org/10.3389/fcvm.2022.901786 Text en Copyright © 2022 Wei, Zhang, Sun, Qi, Huang, Chen, Liu, Sun, Chen, Qin, Xie and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wei, Xu
Zhang, Yili
Sun, Chuanrui
Qi, Baoyu
Huang, Xinyi
Chen, Ming
Liu, Ning
Sun, Kai
Chen, Xin
Qin, Xiaokuan
Xie, Yanming
Zhu, Liguo
Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
title Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
title_full Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
title_fullStr Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
title_full_unstemmed Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
title_short Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
title_sort elucidating the relationship between dyslipidemia and osteoporosis: a multicenter, prospective cohort study protocol
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515467/
https://www.ncbi.nlm.nih.gov/pubmed/36186975
http://dx.doi.org/10.3389/fcvm.2022.901786
work_keys_str_mv AT weixu elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT zhangyili elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT sunchuanrui elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT qibaoyu elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT huangxinyi elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT chenming elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT liuning elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT sunkai elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT chenxin elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT qinxiaokuan elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT xieyanming elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol
AT zhuliguo elucidatingtherelationshipbetweendyslipidemiaandosteoporosisamulticenterprospectivecohortstudyprotocol